On October 6, 2026 Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery powered by AI, reported that management will participate in a fireside chat at the H.C. Wainwright 3rd Annual AI Based Drug Discovery & Development Conference, being held virtually on October 8-9, 2026.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The fireside chat will be held on Thursday, October 8, 2026, at 9:30 AM ET. A live webcast of the presentation will be available on the events page of the Investor Relations section of Compugen’s website at www.cgen.com. A replay will be available following the live event.

(Press release, Compugen, OCT 6, 2026, View Source;Wainwright-3rd-Annual-AI-Based-Drug-Discovery–Development-Conference/default.aspx [SID1234673232])